Biotech Squalane Market to Reach USD 110.6 Million by 2035 | Wilshire Tech, Croda, Sophim Lead – Fact.MR

The global biotech squalane market is expected to reach USD 110.6 million by 2035, up from USD 61.2 million in 2025. During the forecast period 2025 to 2035, the industry is projected to expand at a CAGR of 6.1%.This growth is fueled by increasing consumer demand for sustainable and ethically sourced ingredients, advancements in synthetic biology, and the booming cosmetics and personal care industry. The market is driven by a shift away from shark-derived squalane toward plant-based and fermentation-derived alternatives, aligning with global sustainability trends and regulatory pressures. The United States, Japan, and France are key markets, with France leading growth at a 6.8% CAGR. However, challenges such as high production costs and limited awareness in emerging markets could pose hurdles. The market’s trajectory reflects a broader move toward clean beauty and bio-based innovation, with significant opportunities for stakeholders to capitalize on technological advancements and consumer preferences.

For More Insights, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=10925

Biotech Squalane Market Technology Development:

Technological advancements are at the core of the biotech squalane market’s evolution, particularly in synthetic biology and fermentation technologies. These innovations enable large-scale production of high-purity squalane, offering a sustainable alternative to traditional shark- or olive-derived sources. Precision fermentation, utilizing microbial strains and bio-based feedstocks like sugarcane, has revolutionized squalane production, ensuring consistent quality and cost competitiveness. Companies like Amyris and Croda are leveraging metabolic engineering and scalable bioreactors to optimize production processes, reducing reliance on environmentally taxing raw materials. Additionally, advancements in purification techniques and GMP-approved lipid plants ensure compliance with stringent cosmetic and pharmaceutical standards. The integration of circular bioeconomy principles, such as upcycling agricultural waste (e.g., olive by-products), further enhances sustainability. These technologies align with global clean beauty trends and regulatory demands for cruelty-free, eco-friendly ingredients, positioning biotech squalane as a cornerstone of next-generation cosmetics and pharmaceutical applications.

Biotech Squalane Market Demand and Impact Analysis:

The demand for biotech squalane is driven by the global shift toward sustainable, cruelty-free ingredients, particularly in the cosmetics and personal care sector. With over 66.7% market share in 2025, phyto-derived squalane dominates due to its alignment with clean beauty trends and regulatory bans on animal-derived ingredients. The cosmetics industry, valued at over $500 billion globally, is a key driver, with premium skincare products like moisturizers, serums, and sunscreens incorporating biotech squalane for its stability and emollient properties. Regulatory pressures, especially in Europe and the U.S., are pushing manufacturers to adopt low-impact, bio-based ingredients, boosting demand for fermentation-derived squalane. In pharmaceuticals, squalane’s role as a vaccine adjuvant and topical delivery agent further fuels market growth. However, high production costs, particularly for fermentation processes, and limited awareness in cost-sensitive emerging markets pose challenges. The market’s growth is supported by rising consumer awareness of ethical sourcing and the increasing adoption of eco-certifications, creating opportunities for innovation and market expansion.

Biotech Squalane Market Analysis by Top Investment Segments:

The biotech squalane market is segmented by source (phyto-derived and synthetic squalane), application (cosmetics & personal care, pharmaceutical & biotech, industrial/technical uses), form (liquid and powdered/encapsulated variants), and region. The phyto-derived squalane segment, holding a 66.7% market share in 2025, is the most lucrative, projected to grow at a 6.6% CAGR through 2035. Its dominance stems from consumer preference for plant-based, sustainable ingredients and regulatory support for cruelty-free formulations. The cosmetics and personal care application segment leads due to the global demand for premium skincare and haircare products, accounting for the majority of market revenue. Liquid squalane is the preferred form, valued for its versatility in high-end cosmetic formulations and pharmaceutical applications. Regionally, North America and Europe are key investment hubs due to their advanced biotechnology infrastructure and stringent sustainability regulations. The pharmaceutical segment, driven by squalane’s use in vaccine adjuvants, represents a high-growth opportunity, particularly in the U.S. and Japan. Investors are also eyeing Asia-Pacific, where rapid urbanization and beauty industry growth drive demand for bio-based ingredients.

Biotech Squalane Market Across Top Countries:

The biotech squalane market exhibits distinct regional dynamics, with key countries driving growth:

• United States: The U.S. market, projected to grow at a 4.5% CAGR, is fueled by federal bioeconomy initiatives and a robust clean beauty sector. States like California and Massachusetts are hubs for fermentation technology and synthetic biology, with companies like Amyris leading precision fermentation. The market benefits from FDA support for squalane in vaccine adjuvants and consumer demand for sustainable cosmetics.
• Japan: Japan’s market is advancing at a 6.3% CAGR, driven by its world-renowned cosmetics industry and government-backed sustainability policies. Tokyo and Osaka host R&D centers focusing on bio-based feedstock optimization, with companies like Kuraray and Shiseido incorporating squalane into luxury skincare lines.
• France: Leading with a 6.8% CAGR, France’s market is propelled by its luxury cosmetics industry and circular bioeconomy programs. Companies like Givaudan and Sophim are leveraging olive by-product valorization and eco-certifications to meet demand for high-purity squalane in premium skincare.
• China: As part of the fast-growing Asia-Pacific region, China’s market is driven by its booming beauty industry and increasing biotechnology investments. Consumer awareness of sustainable ingredients is rising, boosting demand for biotech squalane.
• Brazil: An emerging market in Latin America, Brazil’s growth is supported by sugarcane-based fermentation and rising demand for natural cosmetics. Global suppliers are increasingly targeting this region for expansion.

These countries collectively drive global demand, with Asia-Pacific leading due to rapid growth in beauty and biotechnology sectors.

Leading Biotech Squalane Companies and Their Industry Share:

The biotech squalane market is competitive, with key players leveraging sustainable feedstocks and advanced fermentation technologies. Major companies include Wilshire Tech, Caribbean Natural Products Inc., Kuraray, Enepret Inc., Croda Pharma, and Sophim. Amyris and Croda are leaders due to their expertise in precision fermentation and strategic partnerships with cosmetics giants like L’Oréal and Shiseido. Sophim dominates in Europe, particularly France, with its focus on olive-derived squalane and eco-certifications. Kuraray and Nikkol Group lead in Japan, capitalizing on the country’s luxury skincare market. These companies hold significant market share through innovation, scalability, and compliance with global sustainability standards. Strategic initiatives like mergers, acquisitions, and R&D investments are common, with smaller biotech startups also contributing to market fragmentation by offering specialized, high-purity squalane for niche applications. The competitive landscape is shaped by the ability to deliver consistent quality, traceability, and cost-effective production.

Biotech Squalane Market Historic and Future Pathway Analysis:

From 2020 to 2024, the biotech squalane market grew at a CAGR of 5.6%, driven by the shift from shark-derived to bio-based squalane amid rising consumer and regulatory demand for sustainability. The market size increased from approximately USD 45 million in 2020 to USD 61.2 million in 2025. Looking forward, the market is expected to grow at a 6.1% CAGR through 2035, reaching USD 110.6 million. This growth will be driven by advancements in fermentation technology, increasing adoption in cosmetics and pharmaceuticals, and expanding markets in Asia-Pacific and Latin America. The phyto-derived segment will continue to dominate, supported by clean beauty trends and eco-certifications. Challenges include high production costs and feedstock supply variability, particularly for sugarcane-based fermentation. Companies will need to invest in R&D, scalable bioprocessing, and strategic collaborations to overcome these hurdles and capitalize on growing demand for sustainable, high-performance ingredients.

Buy the Full Report Now: https://www.factmr.com/checkout/10925

Biotech Squalane Industry News:

Recent developments highlight the market’s dynamic growth:

• April 2025: Biotechbeauty launched a microbiome-friendly makeup line incorporating biotech squalane, bridging skincare and cosmetics innovation.
• November 2023: Evonik introduced GMP-quality plant-based squalene, signaling advancements in pharmaceutical-grade applications.

These developments reflect the industry’s focus on sustainability, scalability, and innovation. Increasing collaborations between biotech firms and cosmetics giants, along with investments in bio-refinery hubs, are creating new growth opportunities. Regulatory support for cruelty-free and eco-friendly ingredients is driving R&D, ensuring the market aligns with global sustainability goals.

Explore More Related Studies Published by Fact.MR Research:

 Aneurysm Clip Market-https://www.factmr.com/report/1122/aneurysm-clips-market

Heel Pressure Injury Relieving Device Market-https://www.factmr.com/report/1695/heel-pressure-injury-relieving-devices-market

Compression Therapy Device Market-https://www.factmr.com/report/2661/compression-therapy-devices-market

Facial Bone Contouring Market-https://www.factmr.com/report/2819/facial-bone-contouring-market

Fractional Flow Reserve Computed Tomography Market-https://www.factmr.com/report/5260/fractional-flow-reservecomputed-tomography-ffrct-market

About Fact.MR:

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction.

Contact:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Sales Team: sales@factmr.com

Follow Us: LinkedIn | Twitter | Blog